X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PIRAMAL ENTERPRISES ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
 
P/E (TTM) x - 39.0 - View Chart
P/BV x 7.5 3.2 232.7% View Chart
Dividend Yield % 0.6 0.8 76.5%  

Financials

 ALKEM LABORATORIES   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PIRAMAL ENTERPRISES
Mar-17
ALKEM LABORATORIES/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,5892,095 75.8%   
Low Rs1,2321,025 120.2%   
Sales per share (Unadj.) Rs417.5492.8 84.7%  
Earnings per share (Unadj.) Rs56.372.6 77.6%  
Cash flow per share (Unadj.) Rs64.794.7 68.3%  
Dividends per share (Unadj.) Rs12.7021.00 60.5%  
Dividend yield (eoy) %0.91.3 66.9%  
Book value per share (Unadj.) Rs292.9862.5 34.0%  
Shares outstanding (eoy) m119.57172.56 69.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.2 106.7%   
Avg P/E ratio x25.121.5 116.5%  
P/CF ratio (eoy) x21.816.5 132.3%  
Price / Book Value ratio x4.81.8 266.2%  
Dividend payout %22.628.9 77.9%   
Avg Mkt Cap Rs m168,653269,194 62.7%   
No. of employees `000NA4.0 0.0%   
Total wages/salary Rs m9,17117,939 51.1%   
Avg. sales/employee Rs ThNM21,190.3-  
Avg. wages/employee Rs ThNM4,470.1-  
Avg. net profit/employee Rs ThNM3,120.0-  
INCOME DATA
Net Sales Rs m49,91585,037 58.7%  
Other income Rs m1,6452,338 70.4%   
Total revenues Rs m51,56187,374 59.0%   
Gross profit Rs m8,48234,991 24.2%  
Depreciation Rs m1,0063,817 26.4%   
Interest Rs m67120,310 3.3%   
Profit before tax Rs m8,45113,202 64.0%   
Minority Interest Rs m-1141,699 -6.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m1,6062,281 70.4%   
Profit after tax Rs m6,73112,520 53.8%  
Gross profit margin %17.041.1 41.3%  
Effective tax rate %19.017.3 110.0%   
Net profit margin %13.514.7 91.6%  
BALANCE SHEET DATA
Current assets Rs m27,06287,590 30.9%   
Current liabilities Rs m15,324185,578 8.3%   
Net working cap to sales %23.5-115.2 -20.4%  
Current ratio x1.80.5 374.2%  
Inventory Days Days6731 214.3%  
Debtors Days Days4148 86.8%  
Net fixed assets Rs m12,610108,523 11.6%   
Share capital Rs m239345 69.3%   
"Free" reserves Rs m34,490148,481 23.2%   
Net worth Rs m35,027148,826 23.5%   
Long term debt Rs m1,212144,957 0.8%   
Total assets Rs m54,387482,394 11.3%  
Interest coverage x13.61.7 824.4%   
Debt to equity ratio x01.0 3.6%  
Sales to assets ratio x0.90.2 520.6%   
Return on assets %13.66.8 200.0%  
Return on equity %19.28.4 228.4%  
Return on capital %24.912.0 208.0%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56315,001 43.8%   
Fx outflow Rs m3,0125,150 58.5%   
Net fx Rs m3,5529,851 36.1%   
CASH FLOW
From Operations Rs m7,259-100,393 -7.2%  
From Investments Rs m1,864-24,202 -7.7%  
From Financial Activity Rs m-9,273135,705 -6.8%  
Net Cashflow Rs m-15011,110 -1.4%  

Share Holding

Indian Promoters % 66.9 52.9 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 4.0 827.5%  
FIIs % 0.0 26.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 16.5 -  
Shareholders   68,381 93,274 73.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   IPCA LABS  NOVARTIS  SUVEN LIFE  STRIDES SHASUN LTD  WOCKHARDT LTD.  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 19, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - CADILA HEALTHCARE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS